#46 - Robot replacements, Unprofitable buybacks, Objective Corp, Genetic Signatures, & Catapult

Baby Giants Investing

Sep 22, 2022•49 min•Ep. 46

--:--

Listen in podcast apps:

Apple Podcasts

Spotify

Download

Listen to this episode in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Andrew, Matt and Claude, chat through some positive developments in AI and immunology, Charter Hall CEO David Harrison's controversial claim, Russia's conscription, and we answer your questions (oOh!Media, Objective Corporation, Pro Medicus, Genetic Signatures), and Catapult Group International.

-----

1:04 - Good News: AI

3:51 - Good News: Immunology and lupus

4:43 - Charter Hall (ASX: CHC) CEO's controversial claim

12:30 - Biden says U.S. would defend Taiwan

14:38 - Russia's conscription

16:02 - oOh!Media's (ASX: OML) buyback

24:01 - Objective Corporation (ASX: OCL) (1)

30:33 - Pro Medicus (ASX: PME)

32:02 - Objective Corporation (ASX: OCL) (2)

39:27 - Genetic Signatures (ASX: GSS)

41:42 - Catapult Group International (ASX: CAT)

For the best experience, listen in Metacast app for iOS or Android